
Lumos Diagnostics Holdings Ltd (ASX:LDX, OTC:LDXHF) will provide a US commercial update on FebriDx at an investor briefing on October 27, following the planned release of its September-quarter financi

Lumos Diagnostics Holdings Ltd (ASX:LDX, OTC:LDXHF) has appointed healthcare investment specialist Aizaz Syed as a non-executive director, strengthening its board with representation from its largest

Lumos Diagnostics Holdings Limited (LDXHF) Q4 2026 Earnings Call Transcript